Author | Federico Aucejo, MD


What Is the Indication for Sorafenib in Hepatocellular Carcinoma? A Clinical Challenge

March 15, 2011

ByRichard Kim, MD|Michael T. Byrne, DO|Ann Tan, MD|Federico Aucejo, MD

In this review article we will discuss the current data on, and future role of, sorafenib in the treatment of hepatocellular carcinoma beyond Child-Pugh A cirrhosis, in conjunction with local therapy, and in a transplant setting.

Adjuvant Treatment After Orthotopic Liver Transplantation: Is It Really Necessary?

December 16, 2009

ByRichard Kim, MD|Ann Tan, MD|Bassam Estfan, MD|Federico Aucejo, MD

This review summarizes the current data on efficacy and rationale of adjuvant treatment for hepatocellular cancer after orthotopic liver transplantation, as well as future prospects. No adjuvant treatment is currently advocated.